Skip to main content

Table 3 Correlation of the patients’ resistance profile with the co-expression of the three polymorphisms

From: A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients

Verify-now test Cases groups P value (< 0.05)
A group (%) B group (%) C group (%)
Non-resistant 23.6 45.8 30.6 0.003**
Resistant 0 40 60
  1. * Statistically significant (Chi square test)